Together-Breast Cancer Support Platform
Starting soon
Conditions studied: Breast Cancer, Breast Cancer Survivors
In brief
The goal of this study is to evaluate the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors. The main questions it aims to answer are: 1) Is the peer-support program acceptable and sustainable in terms of engagement between mentors and mentees over a 12-week period? 2) Does participation in the program improve quality of life, psychological well-being (including anxiety and depression), and perceived social support? Participants will include Korean speaking breast cancer survivors (mentors) and patients currently undergoing treatment (mentees). After enrollment and matching based on screening information, participants will engage in peer-support interactions through an online platform for 12 weeks. Surveys will be administered at baseline, mid-point, post-intervention, and optional 6-month follow-up to assess outcomes.
Key facts
- Study ID
- NCT07499089
- Run by
- Cedars-Sinai Medical Center
- People needed
- 24
- Starts
- 2026-04-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-03-30
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Mentors:
- Age ≥ 18 years
- Self-identify as Korean
- Able to read, write, and speak both Korean and English
- Diagnosed with breast cancer ≥ 2 years prior to enrollment
- Completed active treatment or currently on long-term maintenance therapy
- Access to a smartphone, computer, or similar device compatible with the study platform
- Willing to participate for at least 3 months
- Willing to complete required training and surveys
- Mentees:
- Age ≥ 18 years
- Self-identify as Korean
- Able to read, write, and speak Korean
- Diagnosed with breast cancer
- Currently receiving treatment (e.g., chemotherapy, radiation therapy, recent surgery, or endocrine therapy)
- Access to a smartphone, computer, or similar device compatible with the study platform
- Willing to participate for at least 3 months
- Willing to complete required surveys
You may not qualify if…
- Individuals who do not meet the inclusion criteria
- Individuals unable to use the online platform or required technology
- Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures)
- Mentees diagnosed with ductal carcinoma in situ (DCIS)
Where it is running
- Cedars Siani Cancer — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.